AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18303254 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 593
Study 16291412 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketotifen fumarate 0.025% ophthalmic solution
Number of subjects: 39
Study 16291412 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical olopatadine HCl 0.1% ophthalmic solution
Number of subjects: 39
Study 16291412 — intervention group
Group type: COMPARATOR
Intervention: Artificial tear substitute (ATS)
Number of subjects: 39
Study 12145231 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg (acute effect)
Number of subjects: 16
Study 12145231 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg (prolonged effect after 2 weeks)
Number of subjects: 16
Study 12145231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acute effect)
Number of subjects: 16
Study 12145231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (prolonged effect after 2 weeks)
Number of subjects: 16
Study 10211849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high intensity exercise (HIGH) - 60 min alternating 5 min running at approximately 90% of VO2max with 5 min brisk walking
Number of subjects: 0
Study 10211849 — intervention group
Group type: COMPARATOR
Intervention: Continuous moderate intensity exercise (MOD) - 60 min continuous run at 60% of VO2max
Number of subjects: 0
Study 10211849 — intervention group
Group type: COMPARATOR
Intervention: Rest (REST)
Number of subjects: 0
Study 7614527 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg twice daily, up to 50 mg if needed) plus hydrochlorothiazide (HCTZ)
Number of subjects: 116
Study 7614527 — intervention group
Group type: COMPARATOR
Intervention: Digoxin (0.1 mg twice daily) plus hydrochlorothiazide (HCTZ)
Number of subjects: 116
Study 2393281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 250 mg
Number of subjects: 0
Study 2393281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 500 mg
Number of subjects: 0
Study 2393281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 1000 mg
Number of subjects: 0
Study 2393281 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 500 mg
Number of subjects: 0
Study 57340 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of steroid drugs plus 600 rads of radiotherapy to the graft
Number of subjects: 36
Study 57340 — intervention group
Group type: COMPARATOR
Intervention: High doses of steroid drugs
Number of subjects: 36
Study 31215985 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1746
Study 31215985 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1746
Study 29067950 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted SI screw fixation
Number of subjects: 30
Study 29067950 — intervention group
Group type: COMPARATOR
Intervention: Freehand SI screw fixation
Number of subjects: 30
Study 26220326 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually-defined therapy program (IT)
Number of subjects: 40
Study 26220326 — intervention group
Group type: COMPARATOR
Intervention: General therapy program (GT)
Number of subjects: 40
Study 26220326 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IT and GT programs
Number of subjects: 40
Study 23066649 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness centering exercise (5 minutes before session)
Number of subjects: 0
Study 23066649 — intervention group
Group type: COMPARATOR
Intervention: No mindfulness centering exercise (control group)
Number of subjects: 0
Study 21584908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 7
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP level in TOF patients at rest
Number of subjects: 20
Study 19492250 — intervention group
Group type: COMPARATOR
Intervention: NT-proBNP level in control healthy children at rest
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP level in TOF patients repaired with transannular patch
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP level in TOF patients operated on without transannular patch
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP level in children with physiological shortening of QRS complex during treadmill test
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP level in patients with prolongation of QRS duration
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP levels in children with severe pulmonary regurgitation
Number of subjects: 20
Study 19492250 — intervention group
Group type: COMPARATOR
Intervention: NT-proBNP levels in children with mild/moderate pulmonary regurgitation
Number of subjects: 20
Study 19492250 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP levels in children with severe tricuspid valve insufficiency
Number of subjects: 20
Study 19492250 — intervention group
Group type: COMPARATOR
Intervention: NT-proBNP levels in children with mild/moderate tricuspid valve regurgitation
Number of subjects: 20
Study 17366867 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal drainage at the conclusion of surgery (GI)
Number of subjects: 23
Study 17366867 — intervention group
Group type: COMPARATOR
Intervention: No drainage applied (GII)
Number of subjects: 23
Study 15330896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of a standard meal within 5 min
Number of subjects: 20
Study 15330896 — intervention group
Group type: COMPARATOR
Intervention: Intake of a standard meal within 30 min
Number of subjects: 20
Study 15330896 — intervention group
Group type: EXPERIMENTAL
Intervention: First postprandial hour
Number of subjects: 20
Study 15330896 — intervention group
Group type: COMPARATOR
Intervention: Second postprandial hour
Number of subjects: 20
Study 11108723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil diet (50 g of oil per 10 MJ)
Number of subjects: 18
Study 11108723 — intervention group
Group type: COMPARATOR
Intervention: Rapeseed oil diet (50 g of oil per 10 MJ)
Number of subjects: 18
Study 11108723 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil diet (50 g of oil per 10 MJ)
Number of subjects: 18
Study 11763909 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil dentifrices
Number of subjects: 170
Study 11763909 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 170
Study 8707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 300 mg
Number of subjects: 17
Study 8707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 600 mg
Number of subjects: 17
Study 8707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 17
Study 1520191 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulation in the first stage and squatting position during the second stage of labour
Number of subjects: 200
Study 1520191 — intervention group
Group type: COMPARATOR
Intervention: Supine position throughout labour
Number of subjects: 200
Study 6240210 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium (ATR) 0.33 mg X kg‐1
Number of subjects: 40
Study 6240210 — intervention group
Group type: EXPERIMENTAL
Intervention: alcuronium (DAN) 0.1 mg X kg‐1
Number of subjects: 40
Study 6240210 — intervention group
Group type: COMPARATOR
Intervention: succinylcholine (SCH) 1.0 mg X kg‐1
Number of subjects: 40
Study 6240210 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium (ATR)
Number of subjects: 40
Study 6240210 — intervention group
Group type: EXPERIMENTAL
Intervention: alcuronium (DAN)
Number of subjects: 40
Study 6240210 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium (ATR) and alcuronium (DAN)
Number of subjects: 40
Study 30044792 — intervention group
Group type: EXPERIMENTAL
Intervention: Anfoleish cream administered 2 times per day (BID group) for 4 weeks
Number of subjects: 80
Study 30044792 — intervention group
Group type: EXPERIMENTAL
Intervention: Anfoleish cream administered 3 times per day (TID group) for 4 weeks
Number of subjects: 80
Study 26823689 — intervention group
Group type: EXPERIMENTAL
Intervention: seCPT (cold water)
Number of subjects: 232
Study 26823689 — intervention group
Group type: COMPARATOR
Intervention: Control (warm water)
Number of subjects: 232
Study 25546691 — intervention group
Group type: EXPERIMENTAL
Intervention: In-plane ultrasound-guided injection with 40 mg of triamcinolone and 1 mL of 1% lidocaine
Number of subjects: 44
Study 25546691 — intervention group
Group type: COMPARATOR
Intervention: Out-plane ultrasound-guided injection
Number of subjects: 44
Study 25546691 — intervention group
Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 44
Study 25546691 — intervention group
Group type: EXPERIMENTAL
Intervention: In-plane ultrasound-guided injection
Number of subjects: 44
Study 23223698 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (n = 50) - quadriceps strengthening exercises, stationary bicycle, hamstrings stretching
Number of subjects: 100
Study 23223698 — intervention group
Group type: COMPARATOR
Intervention: Instruction Group (n = 50) - manual with information about knee osteoarthritis
Number of subjects: 100
Study 19716742 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific neck/shoulder resistance training
Number of subjects: 549
Study 19716742 — intervention group
Group type: EXPERIMENTAL
Intervention: All-round physical exercise
Number of subjects: 549
Study 19716742 — intervention group
Group type: COMPARATOR
Intervention: Reference intervention
Number of subjects: 549
Study 17414691 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label, flexible-dose antidepressant treatment for 8 weeks
Number of subjects: 454
Study 15819755 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training intervention
Number of subjects: 238
Study 15819755 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 238
Study 11931781 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (3 weekly injections as induction, followed by injections every 2 weeks)
Number of subjects: 93
Study 11931781 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen B (two injections at day 1 and day 15 as induction, followed by injections every 4 weeks)
Number of subjects: 93
Study 9536858 — intervention group
Group type: EXPERIMENTAL
Intervention: Triacylglycerols rich in palmitic acid at the sn-2 position
Number of subjects: 8
Study 9536858 — intervention group
Group type: COMPARATOR
Intervention: Triacylglycerols rich in palmitic acid at the sn-1,3 positions
Number of subjects: 8
Study 7632972 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (BMT)
Number of subjects: 135
Study 7632972 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation (BMT)
Number of subjects: 135
Study 7632972 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) after autologous BMT
Number of subjects: 135
Study 7632972 — intervention group
Group type: COMPARATOR
Intervention: No Interleukin-2 (IL-2) after autologous BMT
Number of subjects: 135
Study 2713221 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 3
Study 2713221 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 3
Study 2713221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 28767453 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block
Number of subjects: 31
Study 28767453 — intervention group
Group type: EXPERIMENTAL
Intervention: IV fentanyl
Number of subjects: 31
Study 28767453 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile block
Number of subjects: 31
Study 28767453 — intervention group
Group type: COMPARATOR
Intervention: Control (caudal block vs IV fentanyl vs penile block)
Number of subjects: 31
Study 30128810 — intervention group
Group type: EXPERIMENTAL
Intervention: Community organization partnerships
Number of subjects: 406
Study 30128810 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant referrals
Number of subjects: 406
Study 30128810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnic-based media announcements
Number of subjects: 406
Study 30128810 — intervention group
Group type: EXPERIMENTAL
Intervention: Community organization outreach
Number of subjects: 406
Study 26797499 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine lipoarabinomannan strip test (LAM)
Number of subjects: 457
Study 26797499 — intervention group
Group type: COMPARATOR
Intervention: Sputum smear microscopy (SSM)
Number of subjects: 457
Study 26797499 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM and SSM combined
Number of subjects: 457
Study 26797499 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM
Number of subjects: 457
Study 26797499 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM or SSM alone or combined LAM and SSM
Number of subjects: 457
Study 24513605 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg)
Number of subjects: 50
Study 24513605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21936720 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 60
Study 21936720 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% citric acid
Number of subjects: 60
Study 21936720 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP laser at 1 W, 4.45 J/cm(2)
Number of subjects: 60
Study 21936720 — intervention group
Group type: COMPARATOR
Intervention: 2.5% NaOCl
Number of subjects: 60
Study 19325450 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV coadministered with DTPa-HBV-IPV/Hib and MenC-CRM (Meningitec)
Number of subjects: 1548
Study 19325450 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV coadministered with DTPa-HBV-IPV/Hib and MenC-TT (NeisVac-C)
Number of subjects: 1548
Study 19325450 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV coadministered with DTPa-HBV-IPV and Hib-MenC-TT (Menitorix)
Number of subjects: 1548
Study 19325450 — intervention group
Group type: COMPARATOR
Intervention: 7vCRM (Prevenar/Prevnar) coadministered with DTPa-HBV-IPV and Hib-MenC-TT
Number of subjects: 1548
Study 18628653 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive upper-body resistance training (RT)
Number of subjects: 30
Study 18628653 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) aerobic exercise
Number of subjects: 30
Study 16463664 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate sodium
Number of subjects: 54
Study 16463664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 12898884 — intervention group
Group type: COMPARATOR
Intervention: IL-18 serum concentration measurement
Number of subjects: 14
Study 12898884 — intervention group
Group type: COMPARATOR
Intervention: Flow cytometry analysis
Number of subjects: 14
Study 10357990 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg misoprostol dissolved in acetic acid
Number of subjects: 120
Study 10357990 — intervention group
Group type: COMPARATOR
Intervention: 200 microg misoprostol dissolved in water
Number of subjects: 120
Study 7856825 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0
Study 7856825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine/sulfadoxine (Fansidar)
Number of subjects: 0
Study 2020921 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (600 mg)
Number of subjects: 12
Study 7126418 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (100 mg/day) alone
Number of subjects: 12
Study 7126418 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (100 mg/day) with spironolactone (100 mg/day)
Number of subjects: 12
Study 7126418 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies (Hydrochlorothiazide and spironolactone)
Number of subjects: 12
Study 7126418 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (100 mg/day) once daily
Number of subjects: 12
Study 31151464 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral taurine supplementation
Number of subjects: 50
Study 31151464 — intervention group
Group type: COMPARATOR
Intervention: Weight-loss diet
Number of subjects: 50
Study 28012528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 0.5 mg/kg (maximum dose 16 mg)
Number of subjects: 129
Study 28012528 — intervention group
Group type: COMPARATOR
Intervention: Pre‐incision infiltration of local anesthesia (2-4 ml mixture with saline)
Number of subjects: 129
Study 28012528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 0.5 mg/kg
Number of subjects: 129
Study 28012528 — intervention group
Group type: COMPARATOR
Intervention: Pre‐incision infiltration of local anesthesia
Number of subjects: 129
Study 25612858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g every 24 hours for 4 days)
Number of subjects: 2538
Study 25612858 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke unit care (control group)
Number of subjects: 2538
Study 25612858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 2538
Study 25612858 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2538
Study 23607755 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention group (trained nurses providing brief lifestyle intervention)
Number of subjects: 804
Study 23607755 — intervention group
Group type: COMPARATOR
Intervention: Late intervention group (usual care for first 6 months, then training)
Number of subjects: 804
Study 23607755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (early and late intervention)
Number of subjects: 804
Study 21296446 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoptimal (10^9 cfu/100g of BB-12 and LA-5 and 40mg of green tea extract)
Number of subjects: 58
Study 21296446 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoptimal-10 (10^10 cfu/100g of BB-12, 10^9 cfu/100g of LA-5 and 40mg of green tea extract)
Number of subjects: 58
Study 21296446 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no probiotic, no starter and no green tea extract)
Number of subjects: 58
Study 21296446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 19665347 — intervention group
Group type: EXPERIMENTAL
Intervention: MI pretreatment (Motivational Interviewing)
Number of subjects: 76
Study 19665347 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-CBT (Motivational Interviewing + Cognitive Behavioral Therapy)
Number of subjects: 76
Study 19665347 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (NPT)
Number of subjects: 76
Study 17465500 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 granulocyteaphaeresis sessions
Number of subjects: 20
Study 17465500 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 granulocyteaphaeresis sessions
Number of subjects: 20
Study 14969576 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 320/9 microg twice daily
Number of subjects: 0
Study 14969576 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 0
Study 14969576 — intervention group
Group type: COMPARATOR
Intervention: Formoterol
Number of subjects: 0
Study 14969576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11467142 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-site regimen (0.2 ml at 2 sites on days 0, 3, 7; 1 site on days 28, 90)
Number of subjects: 82
Study 11467142 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-site regimen (0.1 ml at 8 sites on day 0; 4 sites on day 7; 1 site on days 28, 90)
Number of subjects: 82
Study 9747644 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago Psyllium (5 g t.i.d.)
Number of subjects: 125
Study 9747644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 7600397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral approach
Number of subjects: 12
Study 7600397 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous approach
Number of subjects: 12
Study 2848604 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg daily
Number of subjects: 20
Study 2848604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2848604 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 20
Study 30251879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia-Hyperoxia Training (IHHT)
Number of subjects: 32
Study 30251879 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 32
Study 27282835 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) (4 × 5 min 220 mm Hg unilateral occlusion)
Number of subjects: 25
Study 27282835 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (no RIPC)
Number of subjects: 25
Study 24700256 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic LBNP tolerance
Number of subjects: 60
Study 24700256 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic LBNP tolerance
Number of subjects: 60
Study 24700256 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic LBNP tolerance in HIGH group
Number of subjects: 60
Study 24700256 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic LBNP tolerance in LOW group
Number of subjects: 60
Study 24700256 — intervention group
Group type: COMPARATOR
Intervention: Comparison of HIGH and LOW groups under hyperthermia
Number of subjects: 60
Study 23587533 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 119
Study 23587533 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 119
Study 20547600 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium salicylate injections into tender, thickened areas of subcutaneous tissue on the forearm and upper scapular region.
Number of subjects: 40
Study 20547600 — intervention group
Group type: COMPARATOR
Intervention: Sham injections consisting of pressure without skin penetration.
Number of subjects: 40
Study 18400140 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg kg(‐1) administered intravenously over 60 s
Number of subjects: 40
Study 18400140 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.9% NaCl administered intravenously over 60 s (Control Group)
Number of subjects: 40